Brian Puskas, MD
Orthopaedic Surgery · Tigard, ORNPI 1053586016
Payments from drug & device makers
What this record shows
This record is dominated by education: $9,600 of the $11,129 with a category attached, or 86.3%. Steelhead Surgical Inc accounts for 86.7% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2021 at $7,235 and has fallen 98.4% since, to $114 in 2025.
Across 44 payments — averaging $252.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Steelhead Surgical Inc$10K
- Encore Medical, LP$681
- FX Shoulder Solutions, Inc$278
- Johnson & Johnson$125
- Smith+Nephew$82
- Stryker$75
- plus $238 from 10 others
What the payments were for
- Food & beverage$1,52914%
- Education$9,60086%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Steelhead Surgical Inc | 10 | $9,649 |
| Encore Medical, LP | 9 | $681 |
| FX Shoulder Solutions, Inc | 2 | $278 |
| Johnson & Johnson(2 entities) | 4 | $125 |
| Smith+Nephew | 3 | $82 |
| Stryker | 3 | $75 |
| Zimmer Biomet | 3 | $55 |
| Avanos Medical | 2 | $28 |
| Sanofi-aventis U.S. LLC | 1 | $28 |
| Fidia Pharma USA Inc. | 1 | $28 |
| Baxter Healthcare | 1 | $23 |
| Coopersurgical, Inc. | 1 | $19 |
| Pacira Therapeutics, Inc. | 1 | $18 |
| Heron Therapeutics, Inc. | 1 | $17 |
| Bioventus LLC | 1 | $15 |
| Orthofix Medical, Inc. | 1 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$11,129 in reported general payments places this provider in the 80th percentile of 228 orthopaedic surgery providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 33 | $175 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 11 | $107 |
| Cephalexin | 19 | $57 |
| Tramadol Hcl | 13 | $30 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Tigard
- Christopher NansonTigard$73K
- Adam HeisingerTigard$10K
- Mark WagnerTigard$10K
- Patrick DenardMedford$11.5M
- James BallardOregon City$2.4M
- Steven MadeyLake Oswego$1.2M
- Daniel FitzpatrickEugene$481K
- Michelle WelbornPortland$364K
- Elizabeth LiebermanPortland$353K
- Jonathan SalesPortland$303K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.